Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches

@article{Broeck2007CurrentII,
  title={Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches},
  author={B. Van Broeck and C. Van Broeckhoven and S. Kumar-Singh},
  journal={Neurodegenerative Diseases},
  year={2007},
  volume={4},
  pages={349 - 365}
}
During the last 10 years, a lot of progress has been made in unraveling the pathogenic cascade leading to Alzheimer disease (AD). According to the most widely accepted hypothesis, production and aggregation of the amyloid β (Aβ) peptide plays a key role in AD, and thus therapeutic interference with these processes is the subject of intense research. However, some important aspects of the disease mechanism are not yet fully understood. There is no consensus as yet on whether the disease acts… Expand
64 Citations
Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)
  • 16
  • Highly Influenced
New intracellular mechanisms involved in Alzheimer's disease and frontotemporal dementia
GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer's disease?
  • 108
Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD)
  • W. Lukiw
  • Medicine
  • Expert opinion on emerging drugs
  • 2012
  • 49
  • Highly Influenced
Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies
  • A. Drzezga
  • Medicine
  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2007
  • 14
Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).
  • 87
Reassessing the amyloid cascade hypothesis of Alzheimer's disease.
  • S. Pimplikar
  • Biology, Medicine
  • The international journal of biochemistry & cell biology
  • 2009
  • 355
The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
  • 169
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 138 REFERENCES
Tau protein phosphorylation as a therapeutic target in Alzheimer's disease.
  • 61
Aβ40 Inhibits Amyloid Deposition In Vivo
  • 271
  • PDF
Wild-type Presenilin 1 Protects against Alzheimer Disease Mutation-induced Amyloid Pathology*
  • 70
  • PDF
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
  • 1,450
...
1
2
3
4
5
...